Voir/
Métadonnées
Afficher la notice complète
Post-exposure prophylaxis following high-risk contact with Ebola virus, using immunotherapies with monoclonal antibodies, in the eastern Democratic Republic of the Congo: an emergency use program
Langue
EN
Article de revue
Ce document a été publié dans
International Journal of Infectious Diseases. 2021-09-26, vol. 113, p. 166-167
Résumé en anglais
INTRODUCTION: With the development of therapeutics and vaccine against Ebola Virus Disease, the question of post exposure prophylaxis for high risk contact emerged. Immunotherapies (monoclonal antibodies, mAbs) recently ...Lire la suite >
Mots clés en anglais
Ebola virus disease
Post-exposure prophylaxis
Monoclonal antibodies